| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 46.249 | 45.577 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 46.249 | 45.579 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 8.145 | 46.250 | 765 | 480 | 297 | 290 | 97 | 0 | 0 |
| Gross Profit/Loss - EUR | - | 38.104 | -672 | -765 | -480 | -297 | -290 | -97 | 0 | 0 |
| Net Profit/Loss - EUR | - | 36.717 | -1.127 | -765 | -480 | -297 | -290 | -97 | 0 | 0 |
| Employees | - | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Media Agency Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 2.835 | 2.473 | 2.122 | 1.785 | 1.455 | 1.363 | 1.359 | 1.351 |
| Current Assets | - | 40.707 | 43.158 | 41.851 | 40.999 | 40.222 | 39.329 | 39.451 | 39.332 | 39.112 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 40.074 | 43.053 | 41.769 | 40.960 | 40.183 | 39.292 | 39.414 | 39.294 | 39.075 |
| Cash | - | 633 | 105 | 83 | 39 | 38 | 38 | 38 | 38 | 37 |
| Shareholders Funds | - | 36.761 | 35.012 | 33.605 | 32.474 | 31.561 | 30.571 | 30.569 | 30.476 | 30.306 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.945 | 10.981 | 10.720 | 10.647 | 10.445 | 10.213 | 10.245 | 10.214 | 10.157 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Pharma Media Agency Srl